Ocuphire Pharma Inc.

NASDAQ: OCUP · Real-Time Price · USD
1.17
-0.16 (-12.03%)
At close: Oct 23, 2024, 10:00 PM

Ocuphire Pharma Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
-647K 465K 2.18M 8.38M 16.45M 19.01M 19.05M 57.21M 45.27M 41.6M 39.85M -589K -100K n/a n/a 589K 100K n/a
Cost of Revenue
22.97M 23.25M 28M 5.04M 5.03M 4.75M 6K 4K 2.84M 6M 6M 6M 3.17M 3.83M 3.83M 8.17M 9.55M 6.43M
Gross Profit
-25.79M -24.96M -28M 1.17M 11.42M 14.26M 19.04M 57.2M 42.44M 35.6M 33.85M -6.59M -3.27M -3.83M -3.83M -7.58M -9.45M -6.43M
Operating Income
-64.87M -64.3M -62.07M -29.47M -15.08M -12.14M -10.56M 29.08M 18.15M 18.6M 18.23M -22.13M -21.83M -24.03M -22.7M -30.58M -28.29M -22.42M
Interest Income
-100K -100K 500K 1.1M 600K 1M 768K 868K 868K 467K 100K n/a n/a n/a n/a n/a n/a 6.04K
Pretax Income
-58.27M -58.62M -57.53M -27.19M -14.09M -11.29M -9.97M 29.08M 18.97M 19.01M 18.2M -22.37M -22.07M -24.27M -56.69M -69.06M -66.08M -60.55M
Net Income
-58.27M -58.62M -57.53M -27.19M -14.11M -11.3M -9.65M 29.09M 19M 19.03M 17.8M -22.45M -22.15M -24.36M -56.69M -69.06M -66.08M -60.55M
Selling & General & Admin
22.3M 19.89M 18.21M 14.19M 13.36M 14.34M 11.96M 10.73M 10.38M 7.82M 7.27M 6.63M 6.52M 8.15M 8.12M 8.02M 6.99M 4.13M
Research & Development
29.99M 30.05M 26.85M 23.66M 18.17M 16.81M 17.65M 17.4M 16.74M 15.18M 14.36M 15.51M 15.8M 16.46M 15.17M 14.77M 13.03M 9.91M
Other Expenses
-4.76M -4.2M -4.19M -4.19M 565K 2K n/a 46K 53K 68K 68K 22K 17K 3K 4K 10.51M 10.5M 10.51M
Operating Expenses
47.53M 45.19M 40.31M 33.09M 31.52M 31.15M 29.61M 28.13M 27.12M 23M 21.62M 22.13M 22.32M 24.62M 23.29M 22.79M 20.02M 14.04M
Interest Expense
n/a n/a n/a n/a n/a n/a n/a 9K 9K 13K 18K 11K 11K 7K 2K 5.42M 5.6M 6.29M
Selling & Marketing Expenses
-6K -6K -6K -3K -3K -3K -3K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
54.21M 63.65M 73.07M 37.85M 31.53M 31.15M 29.61M 28.13M 27.12M 23M 21.62M 22.13M 22.32M 24.62M 23.29M 22.79M 20.02M 14.04M
Income Tax Expense
5K 3.5K 2K -5K -19K -17.5K -356K -39K -18K 1K 428K 115K 109K 91K 5K 3K 2K 1K
Shares Outstanding (Basic)
63.38M 33.88M 26.72M 26.15M 25.83M 24.52M 22.99M 21.45M 20.96M 20.94M 20.81M 20.5M 19.5M 18.89M 17.73M 16.93M 13.61M 10.92M
Shares Outstanding (Diluted)
63.38M 33.88M 26.72M 26.15M 25.83M 24.52M 22.99M 22.41M 20.96M 20.94M 21.48M 20.5M 19.5M 18.89M 17.85M 16.93M 13.61M 10.92M
EPS (Basic)
-2 -2.18 -2.23 -1.09 -0.54 -0.48 -0.45 1.39 0.91 0.90 0.81 -1.18 -1.21 -1.48 -4.7 -8.08 -8.01 -7.72
EPS (Diluted)
-2 -2.18 -2.23 -1.09 -0.55 -0.49 -0.46 1.33 0.86 0.85 0.76 -1.17 -1.2 -1.47 -4.69 -8.08 -8.01 -7.72
EBITDA
-64.23M -63.65M -61.43M -28.35M -14.44M -11.5M -9.93M 29.08M 18.16M 18.63M 18.17M -22.35M -22.05M -24.26M -56.69M -64.43M -61.6M -55.72M
EBIT
13.31M 4.98M -2.73M -28.36M -14.45M -11.51M -9.93M 29.08M 18.16M 18.63M 18.17M -22.36M -22.05M -24.27M -56.69M -63.63M -60.81M -54.93M
Depreciation & Amortization
-6K -4.5K -3K 6K 7K 6.5K 6K 4K 4K 4K 4K 4K 4K 4K 4K 4K 4K 4K